Page 5 - Indian (NIFTY) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Jul 24, 2024

Discover Indian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NIFTY and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

117 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

531599

FDC
₹505.752.3%48.6%₹82.3bn/aPE27xn/a0%

PAR

Par Drugs and Chemicals
₹244.831.2%25.6%₹3.0bn/aPE20.8xn/a0%

541400

ZIM Laboratories
₹110.752.5%-2.3%₹5.4bn/aPE31.3xn/a0%

524412

Aarey Drugs & Pharmaceuticals
₹50.22-5.4%54.4%₹1.4bn/aPE30.1xn/a0%

DCAL

Dishman Carbogen Amcis
₹166.51-0.9%9.5%₹26.1bn/aPB0.5xn/a0%

VINEETLAB

Vineet Laboratories
₹57.12-7.4%11.9%₹526.6mn/aPE51.3xn/a0%

512529

Sequent Scientific
₹141.60-1.8%60.6%₹35.2bn/aPS2.6xn/a0%

506919

Makers Laboratories
₹135.20-0.2%20.7%₹797.7mn/aPB1.3xn/a0%

532637

Mangalam Drugs & Organics
₹107.701.6%1.1%₹1.7bn/aPB1.3xn/a0%

SOTAC

Sotac Pharmaceuticals
₹146.35-22.6%17.1%₹1.7bn/aPE37.8xn/a0%

539287

Ortin Laboratories
₹19.111.3%-5.4%₹155.4mn/aPS7.4xn/a0%

BROOKS

Brooks Laboratories
₹90.127.9%3.7%₹2.4bn/aPS3xn/a0%

524500

Kilitch Drugs (India)
₹366.209.4%101.2%₹5.9bn/aPE40.3xn/a0%

539997

Kwality Pharmaceuticals
₹511.852.9%50.5%₹5.3bn/aPE22.3xn/a0%

SOLARA

Solara Active Pharma Sciences
₹620.309.7%60.9%₹29.8b₹485.00PS2.3xE107.1%0%

524506

Coral Laboratories
₹690.10-2.9%177.0%₹2.5bn/aPE15.6xn/a0%

538837

Jeevan Scientific Technology
₹51.722.0%-16.2%₹800.6mn/aPS2xn/a0%

524470

Syncom Formulations (India)
₹15.40-1.4%110.4%₹14.5bn/aPE57.2xn/a0%

526953

Venus Remedies
₹384.85-1.1%45.3%₹5.1bn/aPE18.1xn/a0%

WOCKPHARMA

Wockhardt
₹867.752.7%273.1%₹133.1bn/aPS4.7xn/a0%

524654

Natural Capsules
₹326.552.8%-15.3%₹3.0bn/aPE54.8xn/a0%
Page 5 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.